<?xml version="1.0" encoding="ISO-8859-1"?>














<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:html="http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<channel>
<atom:link href="http://www.theheart.org/rssfeed.do" rel="self" type="application/rss+xml" />
<title>theheart.org</title>
<link>http://www.theheart.org/</link>
<description></description>
<image>
 <url>http://www.theheart.org/documents/sitestructure/resources/images/maintho_logo_rss.png</url>
 <title>theheart.org</title>
 <link>http://www.theheart.org/</link>
</image>



	
	
	<item>
	<link>http://www.theheart.org/article/1402037.do</link>
	<title>Genetic study questions HDL levels and the risk of MI</title>
	<description>
	
	   <![CDATA[ The data, from a large-scale genetic analysis, throw cold water on the potential clinical benefits of raising HDL-cholesterol levels to reduce the risk of MI, say investigators. ]]>
	
	</description>
	<pubDate>
	Thu, 17 May 2012 13:45:27 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1402037.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1402011.do</link>
	<title>FDA to review CV risk with azithromycin</title>
	<description>
	
	   <![CDATA[ The agency recently revised the label of an oral-suspension version of the antibiotic to warn about reports of a potentially fatal heart arrhythmia.    ]]>
	
	</description>
	<pubDate>
	Thu, 17 May 2012 13:00:22 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1402011.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1401767.do</link>
	<title>Simple risk score aids carotid-stenting decisions </title>
	<description>
	
	   <![CDATA[ The factors determining a patient's risk during carotid surgery are fairly well-understood, but predicting the risk of carotid stenting patients has so far not been easy, so researchers mined the NCDR database to create a simple risk score that predicts in-hospital major adverse cardiovascular events after carotid stenting. ]]>
	
	</description>
	<pubDate>
	Thu, 17 May 2012 09:15:32 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1401767.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1401795.do</link>
	<title>TAVI numbers rise in Europe as reimbursement, expertise expands</title>
	<description>
	
	   <![CDATA[ New data unveiled at EuroPCR yesterday are offering a fresh snapshot of just how quickly the number of TAVI procedures is increasing in Europe and where these are taking place. ]]>
	
	</description>
	<pubDate>
	Thu, 17 May 2012 09:00:20 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1401795.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1401485.do</link>
	<title>Statins benefit those at much lower CV risk </title>
	<description>
	
	   <![CDATA[ Individual data from 175 000 patients show the benefits of statins greatly outweigh risks even in people with a 10-year risk of CV events of less than 10%. Authors of an accompanying "comment" suggest that everyone over 50 should now be eligible for statin treatment. ]]>
	
	</description>
	<pubDate>
	Wed, 16 May 2012 18:30:30 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1401485.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1401603.do</link>
	<title>Air pollutants mediate effects on heart health through inflammation and thrombosis</title>
	<description>
	
	   <![CDATA[ The Chinese policy of restricting air-pollution emissions during the 2008 Olympic Games allowed researchers to assess the acute effects of air pollution, with the decrease in air pollution reducing von Willebrand factor and P-selectin, two markers of platelet adhesion and activation, as well as C-reactive protein levels in a group of healthy adults. ]]>
	
	</description>
	<pubDate>
	Wed, 16 May 2012 17:15:43 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1401603.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1401581.do</link>
	<title>Azithromycin may up chance of sudden cardiac death </title>
	<description>
	
	   <![CDATA[ In an observational study, during a five-day course of azithromycin therapy, patients had a small, increased chance of dying from sudden cardiac death compared with patients taking amoxicillin. The risk of death was higher among patients with the most baseline cardiovascular risk factors.  ]]>
	
	</description>
	<pubDate>
	Wed, 16 May 2012 17:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1401581.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1400065.do</link>
	<title>So long, Plavix, what a ride! Clopidogrel patent expires</title>
	<description>
	
	   <![CDATA[ Expiration of the clopidogrel patent draws a close to a "fascinating era" in cardiovascular medicine, say experts, having had its largest impact in the ACS and poststenting settings. Yet even as the patent expires there remain some unanswered questions, particularly given the emergence of platelet function and genetic testing for clopidogrel metabolism.  ]]>
	
	</description>
	<pubDate>
	Wed, 16 May 2012 14:45:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1400065.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1401109.do</link>
	<title>COMFORTABLE-AMI: Bioerodable polymer DES trumps bare metal in STEMI</title>
	<description>
	
	   <![CDATA[ The trial is the first randomized controlled trial to show a safety advantage of a DES, investigators say. ]]>
	
	</description>
	<pubDate>
	Wed, 16 May 2012 10:50:23 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1401109.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1400883.do</link>
	<title>COMPARE II: Nobori biolimus stent matches everolimus stents in all-comers</title>
	<description>
	
	   <![CDATA[ While equal to the market-leading Xience/Promus stents in terms of efficacy and safety, the Nobori failed to show an edge where many hope stents with bioerodable polymers will have their niche&#x2014;in reducing stent thrombosis. ]]>
	
	</description>
	<pubDate>
	Wed, 16 May 2012 10:15:12 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1400883.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1400353.do</link>
	<title>Apixaban cuts stroke risk in all types of AF, says ARISTOTLE</title>
	<description>
	
	   <![CDATA[ The trial also had something to say about the degree of stroke risk according to type of atrial fibrillation&#x2014;that is, whether paroxysmal or permanent/persistent.  ]]>
	
	</description>
	<pubDate>
	Wed, 16 May 2012 09:30:43 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1400353.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1399061.do</link>
	<title>FDA panel recommends lorcaserin for obesity</title>
	<description>
	
	   <![CDATA[ The Endocrinologic and Metabolic Drugs Advisory Committee of the FDA has recommended approval of lorcaserin to treat obesity in certain populations. ]]>
	
	</description>
	<pubDate>
	Tue, 15 May 2012 15:45:31 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1399061.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1399013.do</link>
	<title>William O&#39;Neill goes home to lead new structural heart group at Henry Ford</title>
	<description>
	
	   <![CDATA[ Dr William O'Neill is moving from Miami to Detroit to lead a new center for structural heart disease at Henry Ford Hospital. ]]>
	
	</description>
	<pubDate>
	Tue, 15 May 2012 13:45:40 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1399013.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1398969.do</link>
	<title>TAVI to treat surgical valve failure shows potential, with caveats </title>
	<description>
	
	   <![CDATA[ The largest series to date looking at use of a transcatheter valve to treat the failure of a surgically implanted prosthetic has found high rates of survival at one year, but enough in the way of safety signals that investigators are cautioning against widespread use of the practice. ]]>
	
	</description>
	<pubDate>
	Tue, 15 May 2012 13:00:30 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1398969.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1398883.do</link>
	<title>Resuscitation rates in out-of-hospital arrests are woeful</title>
	<description>
	
	   <![CDATA[ Resuscitation rates in out-of hospital cardiac arrest are woefully low, new US research finds, fueled by poor use of bystander CPR and AED employment, which does show some variability according to the race of the victim. But focusing on the "race thing" oversimplifies the problem, say researchers, who also found that AEDs were located too far away from victims in 75% of cases. ]]>
	
	</description>
	<pubDate>
	Tue, 15 May 2012 11:30:05 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1398883.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1398805.do</link>
	<title>FDA: MS drug fingolimod gets CVD warnings</title>
	<description>
	
	   <![CDATA[ The agency completed review of a patient death after the first dose of fingolimod and has updated contraindications and monitoring recommendations for patients with multiple sclerosis.    ]]>
	
	</description>
	<pubDate>
	Tue, 15 May 2012 10:30:36 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1398805.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1398695.do</link>
	<title>Without warfarin, Watchman still prevents strokes, says registry </title>
	<description>
	
	   <![CDATA[ Patients with AF implanted with the left atrial appendage occluder in the earlier PROTECT-AF trial took warfarin the first six weeks; but in warfarin-contraindicated patients, Watchman still protects against stroke, suggests an observational study. ]]>
	
	</description>
	<pubDate>
	Tue, 15 May 2012 10:15:50 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1398695.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1398627.do</link>
	<title>FAME II: FFR pinpoints stable CAD patients who fare worse with OMT </title>
	<description>
	
	   <![CDATA[ Preliminary data showing urgent revascularizations to be more than 10 times higher in patients treated with optimal medical therapy instead of PCI were what prompted the data safety and monitoring board to halt FAME II. ]]>
	
	</description>
	<pubDate>
	Tue, 15 May 2012 09:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1398627.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1398583.do</link>
	<title>Stress echo in asymptomatic patients after revascularization &quot;not worth it&quot; </title>
	<description>
	
	   <![CDATA[ In an observational study of asymptomatic patients who had PCI or CABG and then had a treadmill stress echo, the test did identify at-risk patients. But the patients who then went on to have a repeat revascularization procedure did not have improved survival. Exercise testing is costly and not appropriate for screening asymptomatic patients after revascularization, the group concludes.  ]]>
	
	</description>
	<pubDate>
	Mon, 14 May 2012 17:15:50 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1398583.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1398537.do</link>
	<title>High percentage of New York state PCI cases are for indications of uncertain appropriateness </title>
	<description>
	
	   <![CDATA[ Since recent studies have found wide variation from center to center in the percentage of revascularizations categorized as appropriate by the national appropriate-use criteria, researchers in New York state looked at the registries in their state to see how often bypass surgery and coronary interventions conform to these national guidelines. ]]>
	
	</description>
	<pubDate>
	Mon, 14 May 2012 16:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1398537.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1398161.do</link>
	<title>&quot;Sweet spot&quot; for echo-guided CRT lead placement explored in trial  </title>
	<description>
	
	   <![CDATA[ Device therapy meets personalized medicine: optimal lead positions are different for every patient, but once the leads are in, how close is close enough?   ]]>
	
	</description>
	<pubDate>
	Mon, 14 May 2012 15:45:37 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1398161.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1397783.do</link>
	<title>New guidance for young people with Wolff-Parkinson-White (WPW) syndrome</title>
	<description>
	
	   <![CDATA[ The "first-of-its-kind" consensus statement should help clarify which young people should undergo catheter ablation, authors of the document say. ]]>
	
	</description>
	<pubDate>
	Mon, 14 May 2012 10:00:11 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1397783.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1397759.do</link>
	<title>New angiography appropriateness criteria are SCAI&#39;s latest &quot;quality tool&quot;</title>
	<description>
	
	   <![CDATA[ A multisociety group led by the ACC and SCAI has released new appropriate-use criteria for diagnostic catheterization intended to help clinicians determine when cardiac catheterization is a reasonable option for the evaluation of patients. ]]>
	
	</description>
	<pubDate>
	Sun, 13 May 2012 16:30:35 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1397759.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1397727.do</link>
	<title>Data gathering for Sunshine Act delayed</title>
	<description>
	
	   <![CDATA[ The CMS says that drug and device makers will not have to start collecting data on payments to physicians until 2013.  ]]>
	
	</description>
	<pubDate>
	Fri, 11 May 2012 17:15:19 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1397727.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1397545.do</link>
	<title>RAAFT 2: Catheter ablation can be first line of defense against paroxysmal AF</title>
	<description>
	
	   <![CDATA[ Recurrences were less common for patients who underwent catheter ablation vs antiarrhythmic drug therapy, but it took the right connections for catheter therapy to come out on top. ]]>
	
	</description>
	<pubDate>
	Fri, 11 May 2012 16:30:16 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1397545.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1397471.do</link>
	<title>Moderate coffee intake protects against stroke </title>
	<description>
	
	   <![CDATA[ A new meta-analysis finds that one to three cups of coffee a day may reduce the risk of stroke in the general population and that an even higher intake of up to six cups a day also seems to offer some protection.  ]]>
	
	</description>
	<pubDate>
	Fri, 11 May 2012 15:45:51 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1397471.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1397421.do</link>
	<title>Ixmyelocel-T cell therapy may help DCM patients</title>
	<description>
	
	   <![CDATA[ Cell therapy could be an attractive adjunct for patients with ongoing heart-failure symptoms despite optimal medical and device therapy. A new study shows that a therapy derived from the patient's own bone-marrow cells could fill this role. ]]>
	
	</description>
	<pubDate>
	Fri, 11 May 2012 14:00:28 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1397421.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1397343.do</link>
	<title>Taking STEMI patients to PCI hospitals saves time and lives </title>
	<description>
	
	   <![CDATA[ A new study has found that patients taken directly to a PCI hospital were reperfused an average of 31 minutes faster than patients first taken to a hospital without PCI capability, which was associated with a possible mortality reduction. ]]>
	
	</description>
	<pubDate>
	Fri, 11 May 2012 12:45:16 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1397343.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1397231.do</link>
	<title>Riata revelations: ICD lead failure rates, mechanisms take HRS center stage  </title>
	<description>
	
	   <![CDATA[ Next chapter in the Riata recall story: how often do the leads fail, and why? In one of many Riata-related presentations at the Heart Rhythm Society meeting, the rate was about 2% per patient year. Why is less easily determined. ]]>
	
	</description>
	<pubDate>
	Fri, 11 May 2012 10:30:34 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1397231.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1397027.do</link>
	<title>Robots set to invade interventional world</title>
	<description>
	
	   <![CDATA[ Robotic control devices have become an established part of the surgical field, enabling procedures to be less invasive than ever before. Can the same technology make an impact in coronary interventions? ]]>
	
	</description>
	<pubDate>
	Fri, 11 May 2012 10:15:27 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1397027.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1396867.do</link>
	<title>Femoral vs radial access: Rivals or complements?</title>
	<description>
	
	   <![CDATA[ Over the past few years, transradial coronary interventional access has gone from a small niche to one of the dominant topics at the SCAI annual meeting. Do the results of the RIVAL trial mean this technique completely supplants the traditional transfemoral approach? ]]>
	
	</description>
	<pubDate>
	Thu, 10 May 2012 17:00:35 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1396867.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1396809.do</link>
	<title>Whistleblower suit claiming pioglitazone cover-up implicates Nissen, Cleveland Clinic</title>
	<description>
	
	   <![CDATA[ Dr Helen Ge, a former employee at Takeda, alleges she was fired for repeatedly trying to flag as "serious" the congestive heart failure event reports she was reviewing for the company. She has filed a False Claims Act complaint seeking damages and civil penalties from Takeda on behalf of the US government, which has declined to intervene in the case. ]]>
	
	</description>
	<pubDate>
	Thu, 10 May 2012 16:15:38 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1396809.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1396625.do</link>
	<title>Telemonitoring by pharmacists boosts BP control</title>
	<description>
	
	   <![CDATA[ Initial findings from a US study employing an unusual approach to blood-pressure management&#x2014;whereby pharmacists monitor patients by phone and can make alterations to their therapy&#x2014;are proving encouraging. ]]>
	
	</description>
	<pubDate>
	Thu, 10 May 2012 15:45:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1396625.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1396739.do</link>
	<title>CMO accused by California cardiologists retires  </title>
	<description>
	
	   <![CDATA[ Dr Alfonso Baņuelos, one of four defendants in a case brought by two California cardiologists&#x2014;who allege their superiors at Santa Clara Valley Medical Center ignored their concerns about patient care and retaliated against them as a result of these complaints&#x2014;has retired after 32 years, 10 of which he served as chief medical officer at the institution.  ]]>
	
	</description>
	<pubDate>
	Thu, 10 May 2012 13:30:50 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1396739.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1396675.do</link>
	<title>Pfizer stops promoting Lipitor in US</title>
	<description>
	
	   <![CDATA[ The product lost its patent protection in the US last November. ]]>
	
	</description>
	<pubDate>
	Thu, 10 May 2012 11:30:21 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1396675.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1396425.do</link>
	<title>MRI with pacers, ICDs: Safe, a few minor issues, says MagnaSafe registry </title>
	<description>
	
	   <![CDATA[ Although MRI in device patients may alter some programming and impedance levels temporarily, the scans are associated with few if any important clinical problems, interim analysis of the study suggests. ]]>
	
	</description>
	<pubDate>
	Thu, 10 May 2012 10:00:44 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1396425.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1396379.do</link>
	<title>Waist-hip ratio excels at SCD risk prediction in ARIC cohort</title>
	<description>
	
	   <![CDATA[ Greater waist-to-hip ratio&#x2014;but not two more common obesity measures&#x2014;meant a higher sudden death risk independently of diabetes, CV disease, and heart failure in the community-based cohort study. ]]>
	
	</description>
	<pubDate>
	Thu, 10 May 2012 08:45:07 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1396379.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1396357.do</link>
	<title>Older female AF patients have higher stroke risk</title>
	<description>
	
	   <![CDATA[ Less aggressive care following warfarin prescription is a possible explanation, researchers say.  ]]>
	
	</description>
	<pubDate>
	Wed, 09 May 2012 17:00:02 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1396357.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1396319.do</link>
	<title>ICD shutoff? Yes, say patients, in certain end-of-life scenarios</title>
	<description>
	
	   <![CDATA[ Nearly three-quarters of patients with an ICD would consider shutting it off in specific situations. ]]>
	
	</description>
	<pubDate>
	Wed, 09 May 2012 16:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1396319.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1395957.do</link>
	<title>BP and lipid tests in pharmacies could boost risk-factor control </title>
	<description>
	
	   <![CDATA[ A nationwide campaign in Portugal&#x2014;whereby pharmacy customers were encouraged to have their BP, cholesterol, and BMI assessed in-store&#x2014;has demonstrated that this kind of approach is feasible and that pharmacists can act as good go-betweens for patients and physicians, says one of the researchers. ]]>
	
	</description>
	<pubDate>
	Tue, 08 May 2012 14:15:25 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1395957.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1395933.do</link>
	<title>Mark Midei&#39;s appeal for license reinstatement denied</title>
	<description>
	
	   <![CDATA[ A Maryland judge has turned down Dr Mark Midei's appeal to get back his Maryland medical license. ]]>
	
	</description>
	<pubDate>
	Tue, 08 May 2012 12:50:05 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1395933.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1395849.do</link>
	<title>Dr David Rosenbaum dies, age 54, of pancreatic cancer</title>
	<description>
	
	   <![CDATA[ On Wednesday, Rosenbaum will be awarded a Heart Rhythm Society Lifetime Achievement Award at the HRS 2012 meeting; his name is found throughout the HRS program, where he was scheduled to give a number of lectures. ]]>
	
	</description>
	<pubDate>
	Tue, 08 May 2012 11:00:51 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1395849.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1395245.do</link>
	<title>New IOM report addresses obesity prevention </title>
	<description>
	
	   <![CDATA[ Obesity threatens to undo other health achievements made over the past century, authors warn.    ]]>
	
	</description>
	<pubDate>
	Tue, 08 May 2012 08:30:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1395245.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1395755.do</link>
	<title>Dr Douglas Zipes explains his rare Riata editorial</title>
	<description>
	
	   <![CDATA[ In the latest twist in the Riata lead story, the <i>Heart Rhythm</i> editor in chief published a rare editorial saying he was "compelled to speak out" in defense of the peer-review process that led to his decision to stand by the publication of Hauser et al's paper, after St Jude called for its retraction. ]]>
	
	</description>
	<pubDate>
	Mon, 07 May 2012 17:50:30 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1395755.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1395717.do</link>
	<title>Pulse-pressure amplification study reveals gender differences in cardiovascular risk</title>
	<description>
	
	   <![CDATA[ A new large-scale study shows peripheral pulsatility amplification is independently associated with cardiovascular mortality and that aortic stiffness is a more important factor in women's cardiovascular risk than men's. ]]>
	
	</description>
	<pubDate>
	Mon, 07 May 2012 16:30:22 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1395717.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1395141.do</link>
	<title>Roche stops dalcetrapib trial for lack of benefit</title>
	<description>
	
	   <![CDATA[ Roche has halted the phase 3 trial of dalcetrapib after the interim analysis found the drug was not providing benefit to stable coronary heart disease patients. ]]>
	
	</description>
	<pubDate>
	Mon, 07 May 2012 11:40:06 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1395141.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1394825.do</link>
	<title>Present-day efforts to aid quit-smoking attempts are substandard, says expert</title>
	<description>
	
	   <![CDATA[ Smoking-cessation expert Dr Andrew Pipe said that tobacco addiction is the most monumental of the modifiable cardiovascular risk factors but that the clinical approaches to dealing with smokers are "still rooted firmly in the last century and reflect a unique combination of dogma, misconception, and ignorance." ]]>
	
	</description>
	<pubDate>
	Mon, 07 May 2012 10:15:01 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1394825.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1394751.do</link>
	<title>EUROACTION PLUS: Varenicline aids in smoking cessation</title>
	<description>
	
	   <![CDATA[ In a follow-up to EUROACTION, with the exception that the patients had the option of receiving varenicline, researchers show that a comprehensive, family-based program can reduce smoking rates in high-risk patients and those with vascular disease. ]]>
	
	</description>
	<pubDate>
	Mon, 07 May 2012 09:45:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1394751.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1394517.do</link>
	<title>Cheese, please: Could a little Grana Padano drop your BP?</title>
	<description>
	
	   <![CDATA[ Contrary to the idea that cheese, conventionally quite high in sodium and fat, is not that good for cardiovascular health, a small Italian study finds that Grana Padano might lower blood pressure.  ]]>
	
	</description>
	<pubDate>
	Fri, 04 May 2012 16:15:25 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1394517.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1394469.do</link>
	<title>No advantage for warfarin in heart failure: WARCEF published</title>
	<description>
	
	   <![CDATA[ The authors of a commentary say this large randomized study has provided clinicians with clear answers regarding aspirin vs warfarin in heart failure.  ]]>
	
	</description>
	<pubDate>
	Fri, 04 May 2012 15:00:27 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1394469.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1394397.do</link>
	<title>WHF defends Dubai WCC, reimburses Israelis denied visas</title>
	<description>
	
	   <![CDATA[ The World Heart Federation  is apologizing to Israeli cardiologists who, at the last minute, were denied visas to attend the WCC 2012 in Dubai. One of the Israelis who attended, however, has spoken out to clarify that he and his colleagues "only have good words to say" about their visit to the Emirate city. ]]>
	
	</description>
	<pubDate>
	Fri, 04 May 2012 13:35:21 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1394397.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1394361.do</link>
	<title>More adverse events seen on dabigatran vs warfarin </title>
	<description>
	
	   <![CDATA[ <b><i>UPDATED</i></b> // A new study in patents switched from warfarin to dabigatran has shown a high rate of events necessitating discontinuation of the new drug. ]]>
	
	</description>
	<pubDate>
	Fri, 04 May 2012 13:15:32 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1394361.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1394261.do</link>
	<title>Anhedonia, not depression or anxiety, linked with death following ACS</title>
	<description>
	
	   <![CDATA[ A psychological condition that results in a loss of interest or pleasure in daily activities, anhedonia is associated with an increased long-term risk of death in patients with ACS, new research shows. ]]>
	
	</description>
	<pubDate>
	Fri, 04 May 2012 11:45:11 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1394261.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1394185.do</link>
	<title>Bypass moderate coronary lesions? Taking sides in the debate</title>
	<description>
	
	   <![CDATA[ When is it worth bypassing moderate coronary lesions? In the pathophysiology of CAD progression, as in politics, whether right or left seems to make a difference. ]]>
	
	</description>
	<pubDate>
	Fri, 04 May 2012 11:30:07 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1394185.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1394023.do</link>
	<title>Lifestyle-based primary-prevention program results in weight loss, other changes</title>
	<description>
	
	   <![CDATA[ The multidisciplinary program includes physicians, nurses, physical-activity specialists, social workers, dieticians, and targeted patients referred by family physicians as high risk for cardiovascular events based on their risk-factor profile. ]]>
	
	</description>
	<pubDate>
	Fri, 04 May 2012 10:00:27 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1394023.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1393933.do</link>
	<title>PET/CT attuned to calcium &quot;age&quot; may identify active plaque </title>
	<description>
	
	   <![CDATA[ Noninvasive assessment of coronary plaque biology could greatly improve the identification of metabolically active plaques and risk prediction, so researchers in Scotland are leading the development of a PET/CT method for tracking coronary calcium growth with<sup>18</sup>F-sodium fluoride. ]]>
	
	</description>
	<pubDate>
	Thu, 03 May 2012 17:00:29 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1393933.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1393887.do</link>
	<title>New ESC cardiovascular disease guidelines emphasize primary prevention</title>
	<description>
	
	   <![CDATA[ The guidelines are intended to keep the car engine running before any problems occur, according to the experts.  Prevention and education should ideally start with young parents and continues with children through kindergarten and as they advance through the school system. For adults, secondary prevention can be coordinated through nurse-based activities and by the efforts of general practitioners and cardiologists. ]]>
	
	</description>
	<pubDate>
	Thu, 03 May 2012 14:00:21 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1393887.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1393789.do</link>
	<title>Energy drinks up BP and heart rate; calls for regulation </title>
	<description>
	
	   <![CDATA[ <b><i>UPDATED WITH COMMENTARY</i></b> // A small study illustrates that energy drinks can cause increased blood pressure, tachycardia, and arrhythmias, with those who consume these beverages on a habitual basis being most at risk. The author calls for more research and believes sales of these products should be regulated. ]]>
	
	</description>
	<pubDate>
	Thu, 03 May 2012 12:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1393789.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1393457.do</link>
	<title>Some valve patients are too sick for TAVI or surgery</title>
	<description>
	
	   <![CDATA[ Most of the discussion of PARTNER trial and early rollout of transcatheter valves focused on differentiating TAVI candidates from patients better suited to surgical valve replacement. While experts continue to be alarmed by the number of relatively low-risk patients getting TAVI in some countries, they're also drawing attention to the number of TAVI procedures in patients who are too sick to benefit from any valve replacement. ]]>
	
	</description>
	<pubDate>
	Wed, 02 May 2012 17:40:11 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1393457.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1393357.do</link>
	<title>Lives, money saved by protocol-guided transfusion use at cardiac surgery</title>
	<description>
	
	   <![CDATA[ The bottom line can benefit, if clinical gains aren't enough reason for wide-scale implementation of guidelines for blood-product use with cardiac surgery. ]]>
	
	</description>
	<pubDate>
	Wed, 02 May 2012 16:00:08 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1393357.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1393305.do</link>
	<title>Risk of stroke high when anticoagulant drugs are stopped</title>
	<description>
	
	   <![CDATA[ Analysis of the ROCKET AF trial shows patients are at high risk of stroke when they stop their anticoagulants, underscoring the importance of anticoagulation coverage during the transition to a therapeutic INR. ]]>
	
	</description>
	<pubDate>
	Wed, 02 May 2012 15:30:58 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1393305.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1392925.do</link>
	<title>Ideal blood-pressure goals? &quot;We have no idea&quot; </title>
	<description>
	
	   <![CDATA[ Evidence is lacking for many of the issues that need to be addressed in the field of hypertension, not least the ideal blood-pressure goal for different groups of individuals, experts told the ESH meeting this past weekend.  ]]>
	
	</description>
	<pubDate>
	Wed, 02 May 2012 14:00:36 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1392925.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1392703.do</link>
	<title>More data support pulse oximetry in newborns</title>
	<description>
	
	   <![CDATA[ Review of data on the test in 230 000 babies provides "compelling evidence" for its use for screening for congenital heart defects in clinical practice.  ]]>
	
	</description>
	<pubDate>
	Tue, 01 May 2012 18:30:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1392703.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1392727.do</link>
	<title>CMS restricts TAVI coverage to experienced operators</title>
	<description>
	
	   <![CDATA[ <b><i>UPDATED</i></b> // The coverage policy, which largely echoes the draft decision released in February, emphasizes the importance of the "heart-team" approach, in which surgeons and interventionalists collaborate on valve-repair decisions.  ]]>
	
	</description>
	<pubDate>
	Tue, 01 May 2012 17:20:15 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1392727.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1392655.do</link>
	<title>Small study links Tasers to cardiac arrest</title>
	<description>
	
	   <![CDATA[ <b><i>UPDATED</i></b> // Several case reports have cast doubt on the safety of electronic control devices, commonly known by the brand name Taser. A new study looks at eight cases where a person subdued by one of these devices lost consciousness. ]]>
	
	</description>
	<pubDate>
	Tue, 01 May 2012 15:45:16 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1392655.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1392589.do</link>
	<title>Current CTA studies predict CAD risk in symptomatic, not asymptomatic patients </title>
	<description>
	
	   <![CDATA[ New studies based on CONFIRM registry data of patients presenting with symptoms suggesting CAD show that coronary CT angiography provides incremental risk stratification, experts say. The usefulness of coronary CT angiography for assessing CAD risk in asymptomatic patients remains to be proven, other experts add.   ]]>
	
	</description>
	<pubDate>
	Tue, 01 May 2012 15:00:53 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1392589.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1392561.do</link>
	<title>Older LVAD risk score not effective in current era</title>
	<description>
	
	   <![CDATA[ The destination therapy risk score provided poor discrimination of mortality for LVAD patients receiving the device as a bridge to transplant and modest discrimination for patients who receive LVADs as destination therapy. ]]>
	
	</description>
	<pubDate>
	Tue, 01 May 2012 14:30:34 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1392561.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1392509.do</link>
	<title>CURE-AF: Success up as LA size declines for RF ablation at cardiac surgery </title>
	<description>
	
	   <![CDATA[ But arguably the trial's most important results, according to one expert, underscored a key difficulty in studying surgical procedures. ]]>
	
	</description>
	<pubDate>
	Tue, 01 May 2012 13:15:05 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1392509.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1391337.do</link>
	<title>Mixed findings with vitamin D in hypertension </title>
	<description>
	
	   <![CDATA[ A small, short-term study looking at the effects of high-dose vitamin D on blood pressure in hypertensive subjects in Denmark during the winter months has shown somewhat discrepant results. ]]>
	
	</description>
	<pubDate>
	Mon, 30 Apr 2012 12:30:18 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1391337.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1391201.do</link>
	<title>Long-term cancer risks from cardiac imaging radiation remain unknown</title>
	<description>
	
	   <![CDATA[ Despite a dramatic reduction in radiation doses from coronary computed-tomography angiography scans&#x2014;from about 20 mSv to less than 2 mSv over the past eight years&#x2014;long-term cancer risks from low-level radiation from these tests are still unknown. The tests should be offered to patients only when benefits outweigh potential risks, experts say.  ]]>
	
	</description>
	<pubDate>
	Mon, 30 Apr 2012 11:15:44 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1391201.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1391079.do</link>
	<title>Friend or foe? Uric acid a &quot;probable cause&quot; of CVD </title>
	<description>
	
	   <![CDATA[ Using a unique approach, Israeli researchers have shown that people with so-called "normal" levels of uric acid have a 50% higher risk of hypertension and an almost doubling of diabetes, compared with those with naturally very low uric-acid levels.   ]]>
	
	</description>
	<pubDate>
	Mon, 30 Apr 2012 10:00:47 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1391079.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1391003.do</link>
	<title>Beware valve involvement in device-related infective endocarditis</title>
	<description>
	
	   <![CDATA[ A number of factors were related to higher mortality, but all seemed to have a common thread, in a large international study of infective endocarditis associated with implanted devices. ]]>
	
	</description>
	<pubDate>
	Fri, 27 Apr 2012 17:00:42 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1391003.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1390855.do</link>
	<title>MicroRNAs shown to regenerate cardiac cells </title>
	<description>
	
	   <![CDATA[ Researchers at Duke University have successfully demonstrated that fibroblast scar tissue present in the heart after injury can be converted into cardiomyocytes, by injecting the heart with microRNA molecules.  ]]>
	
	</description>
	<pubDate>
	Fri, 27 Apr 2012 15:00:31 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1390855.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1390821.do</link>
	<title>IMS 3 trial of mechanical embolectomy in stroke stopped</title>
	<description>
	
	   <![CDATA[ Investigators are disappointed at the move to suspend a trial that they hoped would demonstrate effectiveness of mechanical embolectomy, a stroke therapy increasingly used even without this evidence.  ]]>
	
	</description>
	<pubDate>
	Fri, 27 Apr 2012 14:30:02 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1390821.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1390537.do</link>
	<title>Positive vote from FDA advisors for subcutaneous ICD</title>
	<description>
	
	   <![CDATA[ The FDA's Circulatory System Devices Panel voted seven to one in favor of Cameron Health's premarket approval application for its subcutaneously implanted defibrillator. ]]>
	
	</description>
	<pubDate>
	Thu, 26 Apr 2012 17:35:59 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1390537.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1390327.do</link>
	<title>DES or bare-metal stents for primary PCI? New meta-analysis provokes debate </title>
	<description>
	
	   <![CDATA[ <b><i>UPDATED</i></b> // Long-term outcomes with first-generation drug-eluting stents in primary PCI for STEMI show that they have benefits over and above bare-metal stents, say the authors of a new meta-analysis. But an accompanying editorialist is not so sure.  ]]>
	
	</description>
	<pubDate>
	Thu, 26 Apr 2012 13:30:38 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1390327.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1390115.do</link>
	<title>CHA2DS2-VASc score gives best prediction of stroke risk in AF  </title>
	<description>
	
	   <![CDATA[ Another study has suggested that the newer CHA<sub>2</sub>DS<sub>2</sub>-VASc score may be more suitable than the CHADS<sub>2</sub> score, particularly in those at lower risk.  ]]>
	
	</description>
	<pubDate>
	Thu, 26 Apr 2012 09:30:55 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1390115.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1390041.do</link>
	<title>FDA advisors: Benefits trump risks for HeartWare ventricular assist pump</title>
	<description>
	
	   <![CDATA[ The agency revealed little beforehand about which way it was leaning, but its advisory panel, despite disappointment with some of the data, ultimately favored the device's approval. ]]>
	
	</description>
	<pubDate>
	Wed, 25 Apr 2012 18:15:27 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1390041.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1389979.do</link>
	<title>Rise of &quot;hard-core&quot; smokers warrants tailored approaches </title>
	<description>
	
	   <![CDATA[ Tobacco-control legislation, a powerful tool for reducing the number of smokers the world over, may also have the unintended consequences of driving up the numbers of so-called "hard-core smokers"&#x2014;long-term smokers who say they've never attempted to quit and have no intention of trying to do so. ]]>
	
	</description>
	<pubDate>
	Wed, 25 Apr 2012 17:30:11 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1389979.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1389961.do</link>
	<title>Moderate alcohol consumption post-MI lowers risk of mortality</title>
	<description>
	
	   <![CDATA[ Drinking up to two drinks per day was associated with a significant reduction in the risk of all-cause and cardiovascular mortality, but the relationship was U-shaped and diminished if individuals drank to excess. ]]>
	
	</description>
	<pubDate>
	Wed, 25 Apr 2012 17:00:37 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1389961.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1389941.do</link>
	<title>Variation in dual- vs single-chamber-ICD use highlights missing data</title>
	<description>
	
	   <![CDATA[ For patients without an indication for a pacemaker, expert opinions vary on the merits of dual- vs single-chamber implantable defibrillators. One expert says there is a critical need for more research on which device is best. ]]>
	
	</description>
	<pubDate>
	Wed, 25 Apr 2012 16:45:11 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1389941.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1389263.do</link>
	<title>Both hyper- and hypothyroidism linked to CV events </title>
	<description>
	
	   <![CDATA[ Treatment of hypothyroidism with levothyroxine may reduce this risk, at least in younger patients, new data suggest.   ]]>
	
	</description>
	<pubDate>
	Wed, 25 Apr 2012 10:00:39 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1389263.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1389219.do</link>
	<title>ApoA size independently associated with MI</title>
	<description>
	
	   <![CDATA[ The relationship between apoA and MI exists even after adjustment for lipoprotein (a).   ]]>
	
	</description>
	<pubDate>
	Tue, 24 Apr 2012 17:30:40 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1389219.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1389199.do</link>
	<title>Roche recalls two troponin I assays</title>
	<description>
	
	   <![CDATA[ The US Food and Drug Administration issued a class I recall today for the Elecsys troponin I and Elecsys troponin I STAT immunoassays because of concerns about falsely low results. ]]>
	
	</description>
	<pubDate>
	Tue, 24 Apr 2012 17:15:27 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1389199.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1389173.do</link>
	<title>CARGO 2: AlloMap transplant-rejection test works in Europe</title>
	<description>
	
	   <![CDATA[ Researchers hope the findings will lead to wider European use of the gene-expressing profiling test, which they say could mean fewer surveillance endomyocardial biopsies. ]]>
	
	</description>
	<pubDate>
	Tue, 24 Apr 2012 17:00:38 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1389173.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1389009.do</link>
	<title>Cardiologists still earning big bucks, but work frustration abounds</title>
	<description>
	
	   <![CDATA[ US cardiologists earned an average of $314 000 in 2011, with the highest earners being cardiologists working in a single-specialty group practice. Of the responders to the Medscape survey, 54% of cardiologists felt they were inadequately compensated, and just 13% considered themselves wealthy. Only 50% would choose cardiology if they had the chance to select their specialty again. ]]>
	
	</description>
	<pubDate>
	Tue, 24 Apr 2012 17:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1389009.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1388889.do</link>
	<title>Topol is most influential physician executive in new US poll </title>
	<description>
	
	   <![CDATA[ Dr Eric Topol, editor in chief of <b>theheart.org</b>, has been voted the number one most influential physician executive of 2012 in a poll run by <i>Modern </i><i>H</i><i>ealthcare</i>, a US publication covering healthcare business news and research. ]]>
	
	</description>
	<pubDate>
	Tue, 24 Apr 2012 12:00:09 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1388889.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1388847.do</link>
	<title>Dabigatran cuts ICH mortality vs warfarin: RE-LY analysis</title>
	<description>
	
	   <![CDATA[ Actually, once intracranial hemorrhage struck, mortality was about the same in the trial's different groups. But fewer ICHs with dabigatran made for big drop in ICH mortality overall.  ]]>
	
	</description>
	<pubDate>
	Tue, 24 Apr 2012 11:00:21 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1388847.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1388711.do</link>
	<title>Raise the bar for starting primary prevention, cardiologists argue</title>
	<description>
	
	   <![CDATA[ When primary prevention is launched prior to prospective trials evaluating hard outcomes, there remains a possibility that the campaign is instituted in error, authors of a new paper argue, citing niacin, fenofibrate, torcetrapib, and ezetimibe all as evidence in support of their thesis. ]]>
	
	</description>
	<pubDate>
	Tue, 24 Apr 2012 10:00:46 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1388711.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1388735.do</link>
	<title>Court dismisses Mark Midei&#39;s defamation suit</title>
	<description>
	
	   <![CDATA[ The <i>Baltimore Sun</i> is reporting that Midei's suit against St Joseph Medical Center and its parent organization&#x2014;seeking $60 million in compensation, plus up to $540 million in other costs and damages&#x2014;has been dismissed. ]]>
	
	</description>
	<pubDate>
	Tue, 24 Apr 2012 10:00:43 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1388735.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1388659.do</link>
	<title>Diabetes/statin link probed in EFFECT cohort</title>
	<description>
	
	   <![CDATA[ Digging into five years' worth of follow-up data, investigators found no differences in new-onset diabetes related to statin dose. ]]>
	
	</description>
	<pubDate>
	Tue, 24 Apr 2012 09:00:44 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1388659.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1388607.do</link>
	<title>Mall rates? Silent CV risk factors abound in Dubai shoppers</title>
	<description>
	
	   <![CDATA[ Physicians in Dubai have leveraged the Gulf city's best-known asset to shine a light on what they say is a sweeping lack of awareness about cardiovascular risk factors and how to keep them in control. ]]>
	
	</description>
	<pubDate>
	Tue, 24 Apr 2012 08:30:23 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1388607.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1388539.do</link>
	<title>FDG PET/CT can identify infections around implanted device</title>
	<description>
	
	   <![CDATA[ Infections around cardiovascular implantable electronic devices are often difficult to diagnose but important to identify, since extraction is not always simple. So researchers in Quebec tested F-FDG PET/CT imaging to differentiate infections and benign postimplant changes.   ]]>
	
	</description>
	<pubDate>
	Mon, 23 Apr 2012 17:30:05 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1388539.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1388511.do</link>
	<title>ACE inhibitors better ARBs in new meta-analysis in hypertensives </title>
	<description>
	
	   <![CDATA[ <b><i>UPDATED WITH COMMENTARY</i></b> // ACE inhibitors reduced deaths by 10% in a new meta-analysis in hypertensive patients already receiving good, contemporary therapy. In contrast, ARBs had a neutral effect on all-cause mortality. The researchers say the findings provide additional support for the use of ACE inhibitors as first-line treatment for high blood pressure.  ]]>
	
	</description>
	<pubDate>
	Mon, 23 Apr 2012 16:45:41 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1388511.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1388409.do</link>
	<title>Cutting, taxing salt would trim CVD deaths by 3% in half the world</title>
	<description>
	
	   <![CDATA[ A new study modeling the impact of a mere 10% reduction in sodium content in processed foods, combined with adding a 40% tax to salty products in 19 low- and middle-income countries, could lead to 250 000 fewer deaths per year. ]]>
	
	</description>
	<pubDate>
	Mon, 23 Apr 2012 15:30:10 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1388409.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1388179.do</link>
	<title>Statin therapy prior to CABG reduces the risk of postoperative AF</title>
	<description>
	
	   <![CDATA[ Despite the findings, investigators are cautious in their interpretation of the results, noting that patients primarily were treated with atorvastatin and mainly underwent coronary artery bypass graft surgery, making extrapolations to other statins and different types of cardiac surgery difficult. ]]>
	
	</description>
	<pubDate>
	Fri, 20 Apr 2012 16:45:43 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1388179.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1388139.do</link>
	<title>No aliskiren with ACE inhibitors, ARBs in some patients: FDA</title>
	<description>
	
	   <![CDATA[ Aliskiren-containing BP drugs in combination with ACE inhibitors and ARBs are now contraindicated for patients with diabetes based on the aborted ALTITUDE study, the FDA announced. ]]>
	
	</description>
	<pubDate>
	Fri, 20 Apr 2012 15:30:56 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1388139.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1388033.do</link>
	<title>Hands off my wife! Bahrain AED survey points to CPR barriers</title>
	<description>
	
	   <![CDATA[ Controversial findings from a small, survey-based study conducted in the Middle East suggest that Arab men would "not accept" men of other nationalities performing CPR, chest compressions, or applying an AED on a female companion. ]]>
	
	</description>
	<pubDate>
	Fri, 20 Apr 2012 13:00:49 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1388033.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1387851.do</link>
	<title>Lung cancer? Yep, but smokers, globally, are less aware of CVD risks</title>
	<description>
	
	   <![CDATA[ Even more striking, smokers were largely unaware that secondhand smoke increases the risk of heart disease and stroke among nonsmokers, a number that spiked even higher when nonsmokers were questioned. ]]>
	
	</description>
	<pubDate>
	Fri, 20 Apr 2012 09:30:10 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1387851.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1387767.do</link>
	<title>AIM-HIGH fell short, leaving experts looking for reasons in new review</title>
	<description>
	
	   <![CDATA[ The new review attempts to reconcile the disconnect between AIM-HIGH and other positive studies with niacin, particularly since the study failed to support the popular HDL-increasing hypothesis. ]]>
	
	</description>
	<pubDate>
	Thu, 19 Apr 2012 17:00:46 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1387767.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1387705.do</link>
	<title>ADA/EASD issue new hyperglycemia management guidelines</title>
	<description>
	
	   <![CDATA[ The American Diabetes Association and the European Association for the Study of Diabetes have issued a joint position statement on hyperglycemia, emphasizing patient-specific treatment.  ]]>
	
	</description>
	<pubDate>
	Thu, 19 Apr 2012 17:00:25 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1387705.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1387291.do</link>
	<title>XAMOS: Rivaroxaban in real-world orthopedic prophylaxis </title>
	<description>
	
	   <![CDATA[ The trial is said to confirm the benefits shown in the RECORD phase 3 trial program.  ]]>
	
	</description>
	<pubDate>
	Thu, 19 Apr 2012 13:45:30 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1387291.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1387105.do</link>
	<title>TIPS 2: Full-dose polypill boosts efficacy, with no increased side effects</title>
	<description>
	
	   <![CDATA[ The polypill tested in the large, primary-prevention TIPS trial included half-dose formulations of blood-pressure and lipid-lowering drugs, in the hopes of boosting tolerance. Now TIPS 2 shows that a full-dose combination may be feasible in secondary prevention. ]]>
	
	</description>
	<pubDate>
	Thu, 19 Apr 2012 09:15:07 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1387105.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1386845.do</link>
	<title>Marked gender disparities in CVD treatment, outcomes seen in CREATE registry</title>
	<description>
	
	   <![CDATA[ Not only are women experiencing ACS in India less likely to receive appropriate care, they are also more likely to die following treatment, a new analysis shows. ]]>
	
	</description>
	<pubDate>
	Thu, 19 Apr 2012 02:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1386845.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1387075.do</link>
	<title>Endovascular AAA repair safer than open repair in the long run, Medicare data show</title>
	<description>
	
	   <![CDATA[ Endovascular abdominal aortic aneurysm repair reduced 30-day and in-hospital mortality in randomized controlled trials compared with open surgical repair but has not been shown to improve long-term survival. A new study looks at Medicare data to compare the long-term outcomes of the endovascular and open repair of intact AAAs. ]]>
	
	</description>
	<pubDate>
	Wed, 18 Apr 2012 17:15:57 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1387075.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1387047.do</link>
	<title>Medicare Part D coverage gap leads to cardiovascular drug discontinuation </title>
	<description>
	
	   <![CDATA[ Compared with Medicare beneficiaries who received financial assistance to compensate for the gap in coverage, those who reached the Part D spending threshold and received no financial help were greater than 50% more likely to stop taking their medication for a cardiovascular condition, report investigators. ]]>
	
	</description>
	<pubDate>
	Wed, 18 Apr 2012 17:00:14 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1387047.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1387001.do</link>
	<title>ESC issues position paper on new anticoagulants </title>
	<description>
	
	   <![CDATA[ The ESC's Working Group on Thrombosis is enthusiastic about the new drugs in AF, but it is not so impressed with their use in ACS.  ]]>
	
	</description>
	<pubDate>
	Wed, 18 Apr 2012 16:15:30 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1387001.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1386809.do</link>
	<title>AHA: No evidence that gum disease causes CHD </title>
	<description>
	
	   <![CDATA[ A new scientific statement from the American Heart Association pours cold water on the idea that periodontal disease contributes to atherosclerotic vascular disease.  ]]>
	
	</description>
	<pubDate>
	Wed, 18 Apr 2012 16:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1386809.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1386429.do</link>
	<title>SCD risk increased in blacks with HTN, genetics may be key: LIFE analysis</title>
	<description>
	
	   <![CDATA[ Their elevated sudden-death risk was independent of a range of clinical and ECG risk factors, suggesting that "other factors must be playing a role," concluded researchers from the decade-old trial. ]]>
	
	</description>
	<pubDate>
	Wed, 18 Apr 2012 09:30:18 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1386429.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1386449.do</link>
	<title>Tough sell: WCC 2012 course coaxes trainees toward preventive cardiology</title>
	<description>
	
	   <![CDATA[ How to convince young doctors to get involved in CVD prevention, when other areas of cardiology are so alluring&#x2014;and more lucrative? That's a central conundrum underpinning a trainee course that kicked off this year's meeting, in a region where soaring CV risk factors make it a life-and-death question. ]]>
	
	</description>
	<pubDate>
	Wed, 18 Apr 2012 09:15:57 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1386449.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1386379.do</link>
	<title>Report validates risk of high-dose simvastatin</title>
	<description>
	
	   <![CDATA[ Published as a letter to the editor in the <i>Journal of the American Medical Association</i>, a brief report confirms the higher risk of rhabdomyolysis in patients treated with high-dose simvastatin. ]]>
	
	</description>
	<pubDate>
	Tue, 17 Apr 2012 16:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1386379.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1385995.do</link>
	<title>Sleeve gastrectomy reduces diabetes, CV risk factors</title>
	<description>
	
	   <![CDATA[ Sleeve gastrectomy trumps traditional medical therapy for diabetes reduction in an Italian study.    ]]>
	
	</description>
	<pubDate>
	Tue, 17 Apr 2012 10:30:05 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1385995.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1385957.do</link>
	<title>Igaki-Tamai stent safe out to 10 years</title>
	<description>
	
	   <![CDATA[ Long-term data of 50 patients treated with the first fully bioabsorbable stent implanted in the coronary arteries shows the stent to be safe out to 10 years and associated with MACE rates similar to those of bare-metal stents. ]]>
	
	</description>
	<pubDate>
	Mon, 16 Apr 2012 17:15:35 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1385957.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1385921.do</link>
	<title>Maryland set to establish independent review system for PCI</title>
	<description>
	
	   <![CDATA[ The Maryland chapter of the ACC has successfully lobbied the state's legislature to improve oversight of cath labs in the state, although the bill does not include the accreditation requirements the group sought last year. ]]>
	
	</description>
	<pubDate>
	Mon, 16 Apr 2012 16:45:13 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1385921.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1385737.do</link>
	<title>Italian soccer player dies on the pitch</title>
	<description>
	
	   <![CDATA[ An Italian soccer player died of cardiac arrest during a match, just a few weeks after a player in England survived a similar incident. ]]>
	
	</description>
	<pubDate>
	Mon, 16 Apr 2012 13:00:03 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1385737.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1385441.do</link>
	<title>Salt content variable in fast food in different countries</title>
	<description>
	
	   <![CDATA[ Large variations were observed in the salt content between different products, as well as between the same products in different countries. ]]>
	
	</description>
	<pubDate>
	Mon, 16 Apr 2012 12:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1385441.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1385391.do</link>
	<title>AF patients admitted to the hospital on weekends have worse outcomes</title>
	<description>
	
	   <![CDATA[ Previous studies have found that MI patients admitted to the hospital on the weekend generally fare worse than patients arriving during the week, so researchers looked at the same question with regard to atrial-fibrillation patients. ]]>
	
	</description>
	<pubDate>
	Fri, 13 Apr 2012 17:00:34 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1385391.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1385117.do</link>
	<title>Abiomed&#39;s newest Impella pump earns CE Mark</title>
	<description>
	
	   <![CDATA[ Abiomed has announced that its Impella cVAD temporary circulatory support device has been approved for sale in Europe. ]]>
	
	</description>
	<pubDate>
	Thu, 12 Apr 2012 17:00:09 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1385117.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1385087.do</link>
	<title>Five OSU cardiologists earned $1-million bonuses in 2011 </title>
	<description>
	
	   <![CDATA[ The five electrophysiologists earned $1.3 million in bonus pay in 2011, pushing two of the cardiologists over the $2-million mark in total compensation that year. Only Thad Matta, the men's basketball coach, earned more than the doctors. ]]>
	
	</description>
	<pubDate>
	Thu, 12 Apr 2012 16:45:56 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1385087.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1384933.do</link>
	<title>CPR training sessions offered during the Boston Marathon race exposition </title>
	<description>
	
	   <![CDATA[ The Boston Athletic Association, in conjunction with the American Heart Association and the American Red Cross, will be providing free CPR demonstrations for runners, family members, and spectators as they wander through the race exposition. There will be brief sessions to teach compression-only CPR in an attempt to reduce the risk of sudden cardiac death while running the marathon. ]]>
	
	</description>
	<pubDate>
	Thu, 12 Apr 2012 15:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1384933.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1384869.do</link>
	<title>Higher HbA1c levels predict better outcomes in advanced heart failure with diabetes</title>
	<description>
	
	   <![CDATA[ But not in patients with heart failure without diabetes, observed researchers, who suggest that a midrange rather than very low HbA<sub>1c</sub> target may be reasonable in some patients with heart failure.  ]]>
	
	</description>
	<pubDate>
	Thu, 12 Apr 2012 14:15:10 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1384869.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1384629.do</link>
	<title>No mortality risk for losartan vs candesartan seen in heart failure </title>
	<description>
	
	   <![CDATA[ <b><i>UPDATED WITH COMMENTARY</i></b> // Nothing is rotten in the state of Denmark when it comes to the ARB losartan, compared with candesartan, in patients with heart failure&#x2014;unlike what had seemed true in Sweden. ]]>
	
	</description>
	<pubDate>
	Thu, 12 Apr 2012 10:00:24 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1384629.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1384509.do</link>
	<title>ECGs refine risk prediction in seniors, but clinical benefit and cost uncertain</title>
	<description>
	
	   <![CDATA[ Traditional coronary disease risk factors provide a less accurate estimate of risk in older adults than in middle-aged adults, so researchers tested whether electrocardiographic abnormalities that are common in older adults might aid coronary heart disease event prediction. ]]>
	
	</description>
	<pubDate>
	Wed, 11 Apr 2012 17:00:18 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1384509.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1384205.do</link>
	<title>Mobile stroke unit cuts time to treatment</title>
	<description>
	
	   <![CDATA[ Ambulances specially equipped with a CT scanner, laboratory, and telemedicine connection cut "door-to-needle" time in half.  ]]>
	
	</description>
	<pubDate>
	Wed, 11 Apr 2012 14:00:40 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1384205.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1383875.do</link>
	<title>FDA adds VTE risk to drospirenone BCP labels   </title>
	<description>
	
	   <![CDATA[ Despite inconsistent epidemiologic studies, the FDA has concluded that drospirenone-containing oral contraceptives may be linked to a higher risk of venous thromboembolism.  ]]>
	
	</description>
	<pubDate>
	Tue, 10 Apr 2012 17:15:49 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1383875.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1383105.do</link>
	<title>Decision aid leads more patients to skip stress tests</title>
	<description>
	
	   <![CDATA[ Cardiac stress testing in patients at low risk for acute coronary syndrome leads to false-positive test results, so researchers have developed a pictograph that explains patients' risk of acute coronary syndrome and their choices of management. ]]>
	
	</description>
	<pubDate>
	Tue, 10 Apr 2012 16:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1383105.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1383271.do</link>
	<title>Should statins be used in primary prevention? JAMA gets in on the debate  </title>
	<description>
	
	   <![CDATA[ Introduced by the <i>JAMA</i> editors to encourage discussion and debate, the inaugural "dueling viewpoints" kicks off its new series by considering the clinical question of whether or not a healthy 55-year-old male with elevated cholesterol levels should begin taking a statin. ]]>
	
	</description>
	<pubDate>
	Tue, 10 Apr 2012 16:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1383271.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1383847.do</link>
	<title>Hospitals launch medical practices to lure well-insured</title>
	<description>
	
	   <![CDATA[ America's hospitals are busier than ever expanding into new and affluent geographic markets to lure well-insured patients, a strategy that could drive up costs as well as jeopardize independent physician practices, according to a new study. ]]>
	
	</description>
	<pubDate>
	Tue, 10 Apr 2012 16:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1383847.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1383751.do</link>
	<title>How Big Pharma thwarts generics: The case of fenofibrate</title>
	<description>
	
	   <![CDATA[ Authors of a new study argue that physicians could play a bigger role in encouraging the use of generics in order to bring costs down for patients and the healthcare system as a whole. Policy changes could also help make sure market exclusivity was reserved for products that truly offer something new. ]]>
	
	</description>
	<pubDate>
	Tue, 10 Apr 2012 13:45:41 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1383751.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1383769.do</link>
	<title>FDA: Medtronic CRT-Ds get NYHA 2 HF indication</title>
	<description>
	
	   <![CDATA[ Following the majority opinion of an advisory panel last year, the FDA has expanded the indication for Medtronic CRT-D devices to patients with NYHA class 2 heart failure, an LVEF of 30% or less, left bundle branch block, and a QRS duration of 130 ms or more. ]]>
	
	</description>
	<pubDate>
	Tue, 10 Apr 2012 13:30:04 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1383769.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1383311.do</link>
	<title>St Jude: Retract &quot;Riata deaths&quot; journal report</title>
	<description>
	
	   <![CDATA[ <b><i>UPDATED</i></b> // It's urging the peer-reviewed <i>Heart Rhythm</i> to pull a recent analysis of deaths associated with the company's Riata ICD leads, which alleged they are prone to shorting out. The company has even issued its own review of an FDA database, saying it cannot replicate the numbers in the published analysis. ]]>
	
	</description>
	<pubDate>
	Mon, 09 Apr 2012 17:30:24 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1383311.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1383291.do</link>
	<title>Persistent high cholesterol more likely in countries with poorer healthcare systems </title>
	<description>
	
	   <![CDATA[ An international study found that patients with diagnosed high cholesterol or reported use of lipid-lowering agents were more likely to have persistent high cholesterol if they lived in countries with lower national incomes, higher out-of-pocket healthcare expenses, and less efficient healthcare systems. ]]>
	
	</description>
	<pubDate>
	Mon, 09 Apr 2012 17:30:13 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1383291.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1382923.do</link>
	<title>PCI bests meds in stable CAD, but message is &quot;do better meds&quot;</title>
	<description>
	
	   <![CDATA[ Is optimal medical therapy a pipe dream, at least right now? An analysis of clinical-practice data from NY State reopens the COURAGE-oriented debate. ]]>
	
	</description>
	<pubDate>
	Thu, 05 Apr 2012 18:30:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1382923.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1382893.do</link>
	<title>FDA reiterates warning on HeartMate II outflow graft hazard</title>
	<description>
	
	   <![CDATA[ Thoratec is advising customers of potential for malfunction of the HeartMate II LVAD's outflow graft and has updated the device's labeling to help surgeons avoid the problem. ]]>
	
	</description>
	<pubDate>
	Thu, 05 Apr 2012 17:30:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1382893.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1382855.do</link>
	<title>Many left ventriculographies are unnecessary</title>
	<description>
	
	   <![CDATA[ Modern noninvasive imaging of the left ventricle makes traditional left ventriculography obsolete and redundant in many cases, but it is still a common part of angiography procedures. ]]>
	
	</description>
	<pubDate>
	Thu, 05 Apr 2012 16:45:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1382855.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1382737.do</link>
	<title>Incomplete revascularization makes for worse outcomes out to one year</title>
	<description>
	
	   <![CDATA[ The residual SYNTAX score, which is derived from the SYNTAX score used to assess coronary anatomic severity and complexity and calculated after coronary revascularization, was a strong predictor of mortality, MI, and ischemic target lesion revascularization, report investigators. ]]>
	
	</description>
	<pubDate>
	Thu, 05 Apr 2012 16:00:09 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1382737.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1382613.do</link>
	<title>Dr Gary Gibbons named director of the NHLBI</title>
	<description>
	
	   <![CDATA[ Currently at the Morehouse School of Medicine in Atlanta, Gibbons will begin his new role as director of the NHLBI this summer. He is taking over for Dr Susan Shurin, who was named acting director after Dr Elizabeth Nabel left in January 2010.  ]]>
	
	</description>
	<pubDate>
	Thu, 05 Apr 2012 11:30:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1382613.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1382513.do</link>
	<title>Cancer diagnosis ups risk of CV death, suicide</title>
	<description>
	
	   <![CDATA[ A diagnosis of cancer can be so traumatic it can trigger adverse health consequences apart from the cancer, including cardiovascular death. ]]>
	
	</description>
	<pubDate>
	Thu, 05 Apr 2012 10:30:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1382513.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1382455.do</link>
	<title>Mitral regurgitation: Early hazard, later gains following TAVI</title>
	<description>
	
	   <![CDATA[ Mortality in the first 30 days is higher among patients with moderate to severe mitral regurgitation undergoing transcatheter valve implantation. After the first month, however, MR tends to be diminished, supporting a role for TAVI in this high-risk group. ]]>
	
	</description>
	<pubDate>
	Wed, 04 Apr 2012 17:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1382455.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1382419.do</link>
	<title>Medical societies list 45 dubious tests, therapies</title>
	<description>
	
	   <![CDATA[ The American College of Cardiology is one of nine societies that each identified five tests and procedures that are common but often unnecessary, running up the cost of care and sometimes harming a patient's health. ]]>
	
	</description>
	<pubDate>
	Wed, 04 Apr 2012 16:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1382419.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1382251.do</link>
	<title>heartwire&#39;s Lisa Nainggolan picks up AHCJ award</title>
	<description>
	
	   <![CDATA[ Nainggolan's feature story "<i>Lost in transition: The looming epidemic of grown-up congenital heart disease</i>" has placed third in the Association of Health Care Journalists' annual journalism awards in the trade-publication category. ]]>
	
	</description>
	<pubDate>
	Wed, 04 Apr 2012 14:15:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1382251.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1382227.do</link>
	<title>St Jude stops sales of CRT leads with possible insulation problem</title>
	<description>
	
	   <![CDATA[ St Jude Medical is warning physicians to look out for externalized conductors on some of its QuickSite and QuickFlex CRT leads and will stop selling the models possibly affected by this issue. ]]>
	
	</description>
	<pubDate>
	Wed, 04 Apr 2012 13:15:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1382227.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1382217.do</link>
	<title>Sleep-deprived doctors safely perform PCI in small, single-center study</title>
	<description>
	
	   <![CDATA[ In this single-center study, researchers did not find any evidence that middle-of-the-night procedures adversely affect the safety and efficacy of PCIs performed the next day by the same operator. ]]>
	
	</description>
	<pubDate>
	Wed, 04 Apr 2012 13:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1382217.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1381907.do</link>
	<title>Statin therapy changes plaque composition fast </title>
	<description>
	
	   <![CDATA[ Some studies have shown that statin therapy can cause nonatherosclerotic coronary plaques to regress, so the YELLOW trial investigators are trying to determine whether statins can modify the composition and flow physiology of obstructive lesions. ]]>
	
	</description>
	<pubDate>
	Tue, 03 Apr 2012 17:15:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1381907.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1381847.do</link>
	<title>Longer HF hospitalizations cut risk of readmission in analysis</title>
	<description>
	
	   <![CDATA[ Within and outside the US, hospital length of stay was inversely related to 30-day readmissions. But another country had both the longest hospitalizations and the lowest readmission rate. ]]>
	
	</description>
	<pubDate>
	Tue, 03 Apr 2012 16:45:09 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1381847.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1381697.do</link>
	<title>Waist measurements linked with lipids, BP, in youth  </title>
	<description>
	
	   <![CDATA[ In multivariate regression models that adjusted for age and sex, increasing waist-to-height ratios were significantly associated with worsening lipid profiles across BMI strata, with the strongest association observed in obese patients. ]]>
	
	</description>
	<pubDate>
	Tue, 03 Apr 2012 13:45:35 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1381697.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1381673.do</link>
	<title>Cardiologist becomes dean at University of Alberta</title>
	<description>
	
	   <![CDATA[ The University of Alberta has named Dr Douglas Miller as its permanent dean of medicine after a turbulent period that began when the former dean was accused of plagiarizing a speech. ]]>
	
	</description>
	<pubDate>
	Tue, 03 Apr 2012 13:00:19 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1381673.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1381381.do</link>
	<title>CPR may save people with unshockable arrhythmias </title>
	<description>
	
	   <![CDATA[ The 2010 American Heart Association cardiopulmonary-resuscitation guidelines emphasize uninterrupted chest compressions, an approach shown in several studies to save lives of people in so-called "shockable" cardiac arrest. A new study evaluates the benefits of this approach for "unshockable" cardiac arrest. ]]>
	
	</description>
	<pubDate>
	Mon, 02 Apr 2012 16:30:25 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1381381.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1381337.do</link>
	<title>TWENTE published: Resolute matches Xience V stent</title>
	<description>
	
	   <![CDATA[ The Resolute zotarolimus-eluting stent was shown to be noninferior to the Xience everolimus-eluting stent in the treatment of "real-world" patients with complex lesions and when used for off-label indications. ]]>
	
	</description>
	<pubDate>
	Mon, 02 Apr 2012 16:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1381337.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1381253.do</link>
	<title>Arrhythmic risk can stay elevated even after improved LVEF</title>
	<description>
	
	   <![CDATA[ Could an LVEF that has risen above 35% since ICD implantation indicate less need for a replacement device?  ]]>
	
	</description>
	<pubDate>
	Mon, 02 Apr 2012 15:00:59 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1381253.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1380849.do</link>
	<title>Oral anticoagulants in the real world: Bleeding rates and medical costs compared </title>
	<description>
	
	   <![CDATA[ Two separate experiences with dabigatran from different US centers showing very different results, and new cost-effectiveness analyses with the new drugs were reported in a poster session at last week's ACC meeting.  ]]>
	
	</description>
	<pubDate>
	Mon, 02 Apr 2012 11:45:35 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1380849.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1380719.do</link>
	<title>Low BMI may up complication, mortality risk at ICD implantation</title>
	<description>
	
	   <![CDATA[ Some simple precautions might help prevent the two most common complications that were seen in underweight patients. ]]>
	
	</description>
	<pubDate>
	Mon, 02 Apr 2012 11:15:52 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1380719.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1380655.do</link>
	<title>Rivaroxaban gets NICE nod in UK for AF </title>
	<description>
	
	   <![CDATA[ In its final draft guidance, the UK National Institute for Clinical Excellence has recommended<b> </b>rivaroxaban as an option for the prevention of stroke and systemic embolism in people with atrial fibrillation. ]]>
	
	</description>
	<pubDate>
	Mon, 02 Apr 2012 09:30:31 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1380655.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1380521.do</link>
	<title>Comparison of risk-assessment strategies favors &quot;statins for all&quot;</title>
	<description>
	
	   <![CDATA[ The multiple approaches to risk-stratifying patients at risk for coronary disease help to identify which patients should take statins, but the comparative cost and effectiveness of these strategies is unknown. So researchers conducted a sophisticated statistical comparison of five approaches. ]]>
	
	</description>
	<pubDate>
	Mon, 02 Apr 2012 07:45:01 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1380521.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1380393.do</link>
	<title>Solid four-year safety and efficacy data with biodegradable-polymer DES </title>
	<description>
	
	   <![CDATA[ Treatment with the biodegradable-polymer drug-eluting stents significantly reduced the risk of target lesion revascularization 18% and stent thrombosis 44% compared with the Cypher stent. The reduction in stent thrombosis was driven by a significant reduction in the risk of very late stent thrombosis. ]]>
	
	</description>
	<pubDate>
	Fri, 30 Mar 2012 14:30:15 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1380393.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1380075.do</link>
	<title>New analysis extends dabigatran MI signal to other thrombin inhibitors </title>
	<description>
	
	   <![CDATA[ A new meta-analysis of trials of dabigatran and its almost-forgotten, long-lost cousin, ximelagatran, shows that there is a signal of increased MI with use of direct thrombin inhibitors. The novel findings were dissected and digested at the ACC Scientific Sessions earlier this week.  ]]>
	
	</description>
	<pubDate>
	Fri, 30 Mar 2012 11:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1380075.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1379979.do</link>
	<title>FDA advisors: &quot;Safe&quot; obesity drugs need to prove absence of cardiovascular risk</title>
	<description>
	
	   <![CDATA[ If the FDA follows the recommendations, drug companies will have to either conduct phase 2 to 3 trials or do meta-analyses that rule out excess cardiovascular risk for new obesity drugs that do not have a signal for cardiovascular risk. Advisors voted 17 to 6 in favor of a cardiovascular-safety benchmark that equals the one for diabetes drugs.  ]]>
	
	</description>
	<pubDate>
	Fri, 30 Mar 2012 10:00:57 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1379979.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1379875.do</link>
	<title>Low rate of residual stroke with warfarin </title>
	<description>
	
	   <![CDATA[ A contemporary meta-analysis of trial data shows a 1.66% annual rate of stroke with current use of warfarin in patients with nonvalvular atrial fibrillation.  ]]>
	
	</description>
	<pubDate>
	Thu, 29 Mar 2012 17:10:44 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1379875.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1379797.do</link>
	<title>Antipsychotics linked to MI risk in dementia patients</title>
	<description>
	
	   <![CDATA[ Antipsychotic medications are associated with a modest and time-limited increase in risk for MI in elderly patients with dementia. ]]>
	
	</description>
	<pubDate>
	Thu, 29 Mar 2012 16:30:12 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1379797.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1379415.do</link>
	<title>Riata ICD lead failures: Focus shifts to short-circuit risk </title>
	<description>
	
	   <![CDATA[ Abraded insulation and exposed cables were only the beginning of the leads' safety issues. They haven't been implanted in well over a year, but lots of people still have them. ]]>
	
	</description>
	<pubDate>
	Thu, 29 Mar 2012 13:45:29 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1379415.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1379471.do</link>
	<title>RAPID GENE: Point-of-care genetic test singles out clopidogrel nonresponders</title>
	<description>
	
	   <![CDATA[ Patients in the RAPID GENE test, randomized to undergo point-of-care gene testing, then given prasugrel instead of clopidogrel if found to be carriers of the CYP2C19*2 allele, were significantly less likely to demonstrate high on-treatment platelet reactivity seven days post-PCI. ]]>
	
	</description>
	<pubDate>
	Thu, 29 Mar 2012 12:00:42 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1379471.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1379495.do</link>
	<title>FDA committee members grapple with cardiovascular risks in obesity drugs </title>
	<description>
	
	   <![CDATA[ In day one of a two-day meeting, members of the FDA Endocrinologic and Metabolic Drugs Advisory Committee heard from experts in obesity, diabetes, cardiology, and statistics. Later today, the panel will vote on whether obesity drugs with no cardiovascular risk signal still need to rule out excess cardiovascular risk.  ]]>
	
	</description>
	<pubDate>
	Thu, 29 Mar 2012 11:00:37 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1379495.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1379355.do</link>
	<title>Non-HDL-C levels linked to risk of cardiovascular events</title>
	<description>
	
	   <![CDATA[ LDL-C levels have traditionally been used to determine when to start statin therapy, but a new meta-analysis suggests that non-HDL-C might be a better target. ]]>
	
	</description>
	<pubDate>
	Wed, 28 Mar 2012 17:00:31 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1379355.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1378049.do</link>
	<title>Figure-8-shaped vena cava filter shows promise</title>
	<description>
	
	   <![CDATA[ The Crux vena cava filter was 98% successful in the RETRIEVE clinical trial, and its designers hope it will avoid the problems that have plagued other vena cave filters in recent years. ]]>
	
	</description>
	<pubDate>
	Wed, 28 Mar 2012 10:00:35 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1378049.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1377765.do</link>
	<title>MOPETT: Is half-dose thrombolysis feasible for moderate PE? </title>
	<description>
	
	   <![CDATA[ New results from a pilot trial suggest that a half dose of the thrombolytic tPA, in combination with a reduced anticoagulation regime, could be used to successfully treat around 70% of patients presenting to the emergency room with pulmonary embolism, resulting in improved outcomes with no severe adverse effects. But others were not convinced. ]]>
	
	</description>
	<pubDate>
	Tue, 27 Mar 2012 16:30:08 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1377765.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1377689.do</link>
	<title>New oral anticoagulants in AF: What to do in clinical practice </title>
	<description>
	
	   <![CDATA[ In a talk entitled "Putting it all together: What should we do now?" Prof John Camm attempted to make some recommendations on how the new drugs should be incorporated into clinical practice.  ]]>
	
	</description>
	<pubDate>
	Tue, 27 Mar 2012 15:45:51 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1377689.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1377635.do</link>
	<title>BCIS-1: IABP associated with a long-term reduction in mortality</title>
	<description>
	
	   <![CDATA[ Researchers report that the elective use of IABP during PCI was associated with a 34% reduction in the risk of death after a median follow-up of 51 months. They were cautious in interpreting the data, however, noting that further studies are needed to determine if the finding is real.  ]]>
	
	</description>
	<pubDate>
	Tue, 27 Mar 2012 14:30:52 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1377635.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1376069.do</link>
	<title>IMMEDIATE: EMS-given GIK fails to slow unstable angina&#39;s march to MI</title>
	<description>
	
	   <![CDATA[ <b><i>UPDATED WITH COMMENTARY </i></b> // Out-of-hospital glucose-insulin-potassium, administered by emergency medical services in the first hours of a suspected ACS event, failed to reduce the progression of unstable angina to MI and was not associated with an improvement in 30-day survival rates. Still, the researchers are excited that GIK reduced infarct size and don't think that GIK should be abandoned just yet.  ]]>
	
	</description>
	<pubDate>
	Tue, 27 Mar 2012 09:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1376069.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1377143.do</link>
	<title>ASCERT CABG, PCI analysis: Lower mortality with surgery</title>
	<description>
	
	   <![CDATA[ <b><i>UPDATED WITH COMMENTARY</i></b> // Four-year survival was significantly better with bypass surgery than PCI for patients with two- and three-vessel stable CAD. Did the analysis adequately control for risk, or does that miss the point? ]]>
	
	</description>
	<pubDate>
	Tue, 27 Mar 2012 09:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1377143.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1376891.do</link>
	<title>ROMICAT II: CT-first ACS strategy matches current practice</title>
	<description>
	
	   <![CDATA[ <b><i>UPDATED WITH COMMENTARY</i></b> // Results of the 1000-patient ROMICAT II trial provide more evidence that screening chest-pain patients with computed tomography saves time without a noticeable risk of accidentally discharging a patient having a heart attack, but it does not appear to save money. ]]>
	
	</description>
	<pubDate>
	Tue, 27 Mar 2012 09:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1376891.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1376983.do</link>
	<title>ISSUE-3: DDD pacing can help suppress asystolic neurally mediated syncope</title>
	<description>
	
	   <![CDATA[ Patient selection was likely the key to the success of pacemaker therapy, according to researchers:  all randomized patients had shown what was considered likely to be that form of syncope during implantable-loop-recorder monitoring. ]]>
	
	</description>
	<pubDate>
	Mon, 26 Mar 2012 19:10:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1376983.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1376609.do</link>
	<title>New monoclonal antibody to PCSK9 impresses with LDL-cholesterol reductions</title>
	<description>
	
	   <![CDATA[ Among a group of patients treated with atorvastatin who still had elevated cholesterol levels, treatment with the new compound reduced LDL cholesterol by more than 70% from baseline. Researchers called it a "wow" moment, while others, equally impressed, said that hard clinical outcomes will be the drug's true measure.  ]]>
	
	</description>
	<pubDate>
	Mon, 26 Mar 2012 17:15:20 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1376609.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1376649.do</link>
	<title>Start lowering LDL in childhood, new study suggests</title>
	<description>
	
	   <![CDATA[ Results of a "natural" randomized trial using genetic data suggest that lowering LDL early in life has a much greater potential to reduce heart disease than starting treatment later in life. ]]>
	
	</description>
	<pubDate>
	Mon, 26 Mar 2012 17:15:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1376649.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1373991.do</link>
	<title>Most ICD implants appropriate, more detailed chart notes may be needed</title>
	<description>
	
	   <![CDATA[ An audit of a suburban New York hospital highlighted a gap between national coverage determination directives for ICD implants and clinical practice based on medical judgment and more updated professional society guidelines. Despite this, less than 2% of implants were deemed inappropriate at the hospital. ]]>
	
	</description>
	<pubDate>
	Mon, 26 Mar 2012 16:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1373991.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1376205.do</link>
	<title>EINSTEIN PE: Rivaroxaban equals standard therapy, halves major bleeding </title>
	<description>
	
	   <![CDATA[ The new oral factor Xa inhibitor rivaroxaban proved equivalent to standard care of LMWH plus vitamin-K antagonist for the treatment of acute pulmonary embolism in the EINSTEIN PE study reported today. The new drug also halved major bleeds, in particular the troublesome intracranial hemorrhage, said the investigator. Commentators said they eagerly await cost-effectiveness data. ]]>
	
	</description>
	<pubDate>
	Mon, 26 Mar 2012 15:00:17 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1376205.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1374975.do</link>
	<title>STAMPEDE: Bariatric surgery betters standard diabetes treatment in the obese</title>
	<description>
	
	   <![CDATA[ <b><i>UPDATED</i></b> // Findings from two randomized trials showed that bariatric surgery was considerably better than traditional medical therapy for controlling type 2 diabetes in obese patients, independent of weight loss. But critics caution that much longer-term data are needed&#x2014;to show actual changes in the serious complications of diabetes in years to come&#x2014;before this "huge intervention" can be considered as a valid treatment for the condition.  ]]>
	
	</description>
	<pubDate>
	Mon, 26 Mar 2012 11:30:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1374975.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1374793.do</link>
	<title>Transcatheter valves in inoperable patients at two years: PARTNER B</title>
	<description>
	
	   <![CDATA[ Two-year outcomes in the PARTNER B trial, testing transcatheter aortic-valve replacement against best medical care in inoperable patients, have now been published<i>.</i> ]]>
	
	</description>
	<pubDate>
	Mon, 26 Mar 2012 09:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1374793.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1374915.do</link>
	<title>CCTA-first ER strategy safely discharges more patients: ACRIN/PA</title>
	<description>
	
	   <![CDATA[ <b><i>UPDATED </i></b>// Most patients presenting to the emergency department with suspected acute coronary syndrome are not suffering from it, so CCTA, with its high negative-predictive value, is an attractive option as an initial screening tool. ]]>
	
	</description>
	<pubDate>
	Mon, 26 Mar 2012 09:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1374915.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1374715.do</link>
	<title>PARTNER A: Even mild paravalvular leaks linked with higher mortality at two years</title>
	<description>
	
	   <![CDATA[ <b><i>UPDATED </i></b><b>//</b><b> </b>A phenomenon virtually unheard of in the surgical valve-replacement era, paravalvular leaks were linked with higher mortality, although overall mortality rates were no different between surgery- and TAVR-treated patients. Investigators are calling paravalvular regurgitation a new "target" that could potentially further improve TAVI results. ]]>
	
	</description>
	<pubDate>
	Mon, 26 Mar 2012 09:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1374715.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1375459.do</link>
	<title>CORONARY: Off-pump and on-pump CABG give similar short-term outcomes </title>
	<description>
	
	   <![CDATA[ The largest study ever to compare the two techniques has shown similar 30-day results for the primary end point. Differences in secondary end points may drive decisions on an individual basis until long-term results are available, suggests the lead author.  ]]>
	
	</description>
	<pubDate>
	Mon, 26 Mar 2012 09:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1375459.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1375585.do</link>
	<title>MI in pregnancy &quot;a different entity&quot; </title>
	<description>
	
	   <![CDATA[ MI in pregnancy or in the postpartum period creates a host of issues that are different from a conventional heart attack, data from a new survey of such cases show. ]]>
	
	</description>
	<pubDate>
	Mon, 26 Mar 2012 07:30:14 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1375585.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1375197.do</link>
	<title>Renal-denervation debate centers on response time</title>
	<description>
	
	   <![CDATA[ <b><i>CORRECTED </i></b>//<b> </b>A session updating attendees on the latest findings from studies on renal denervation for severe resistant hypertension attracted much attention today. ]]>
	
	</description>
	<pubDate>
	Sun, 25 Mar 2012 19:30:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1375197.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1375049.do</link>
	<title>Low levels of LDL cholesterol predate cancer cases by nearly two decades</title>
	<description>
	
	   <![CDATA[ The analysis, which used data from the Framingham Heart Study and included patients not currently taking lipid-lowering medications, puts a kibosh on hypotheses suggesting that cancer causes low LDL-cholesterol levels, say investigators. ]]>
	
	</description>
	<pubDate>
	Sun, 25 Mar 2012 17:45:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1375049.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1375033.do</link>
	<title>Black and white athletes need separate screening guidelines</title>
	<description>
	
	   <![CDATA[ Preparticipation cardiac screening for athletes leads too many false positives, especially in black athletes, so a group in England has refined the screening process to account for racial differences in training-related cardiac changes that are sometimes mistaken for dangerous heart conditions. <tab/> ]]>
	
	</description>
	<pubDate>
	Sun, 25 Mar 2012 17:30:04 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1375033.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1373941.do</link>
	<title>BRIDGE ACS: Quality initiative leads to more evidence-based ACS care</title>
	<description>
	
	   <![CDATA[ BRIDGE-ACS evaluated how a coordinated education strategy could improve the Brazilian hospitals' adherence to evidence-based medicine for acute coronary syndromes.  ]]>
	
	</description>
	<pubDate>
	Sun, 25 Mar 2012 09:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1373941.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1374039.do</link>
	<title>C-PORT E nine-month results: Elective PCI doesn&#39;t need surgery safety net</title>
	<description>
	
	   <![CDATA[ <b><i>UPDATED WITH INTERVIEW</i></b> // Consistent with the trial's already-reported six-week outcomes, the rate of major adverse complications at nine months was about the same regardless of the presence of on-site cardiac surgery. ]]>
	
	</description>
	<pubDate>
	Sun, 25 Mar 2012 09:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1374039.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1373805.do</link>
	<title>INFUSE-AMI: Intracoronary abciximab, not thrombectomy, reduces infarct size</title>
	<description>
	
	   <![CDATA[ <b><i>UPDATED WITH COMMENTARY</i></b> // The intracoronary administration of abciximab delivered to the infarct lesion site resulted in a significant, albeit modest, reduction in infarct size in patients presenting with a large anterior STEMI, new research shows. ]]>
	
	</description>
	<pubDate>
	Sun, 25 Mar 2012 09:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1373805.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1374555.do</link>
	<title>Dick Cheney gets a new heart</title>
	<description>
	
	   <![CDATA[ Former vice president Dick Cheney received a heart transplant today, according to a statement released by his office. He is currently recovering in the intensive care unit of Inova Fairfax Hospital in Falls Church, VA. ]]>
	
	</description>
	<pubDate>
	Sat, 24 Mar 2012 20:15:31 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1374555.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1374363.do</link>
	<title>Dr Eric Peterson to take the reins at Duke Clinical Research Institute</title>
	<description>
	
	   <![CDATA[ The accomplished outcomes researcher and clinician has been named the new DCRI director, as the current director heads to Stanford later this year. ]]>
	
	</description>
	<pubDate>
	Sat, 24 Mar 2012 19:00:55 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1374363.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1374241.do</link>
	<title>Patients with high calcium score more likely to lose weight, take statins</title>
	<description>
	
	   <![CDATA[ Researchers showed patients the calcium in their coronary arteries using scans to find out whether actually seeing coronary disease would motivate more patients to take statins or lose weight. ]]>
	
	</description>
	<pubDate>
	Sat, 24 Mar 2012 16:30:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1374241.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1374163.do</link>
	<title>TAVI registry updates ADVANCE the field, raise hopes for lower stroke rates</title>
	<description>
	
	   <![CDATA[ Low stroke rates in two registries tracking outcomes for the two leading transcatheter valves are raising hopes that the cerebrovascular events that concerned people in the pivotal PARTNER trial may not necessarily represent the real-world occurrence of this problem going forward. ]]>
	
	</description>
	<pubDate>
	Sat, 24 Mar 2012 16:25:34 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1374163.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1374141.do</link>
	<title>Anti-inflammatory bindarit cuts in-stent late loss with bare-metal stents</title>
	<description>
	
	   <![CDATA[ Although the drug was superior to placebo, investigators say in-stent late loss needs to decline further for bindarit, an anti-inflammatory compound that selectively inhibits monocyte chemotactic proteins, to be valuable in clinical practice. ]]>
	
	</description>
	<pubDate>
	Sat, 24 Mar 2012 16:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1374141.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1374065.do</link>
	<title>GIFT exome analysis unearths two new genes related to platelet function </title>
	<description>
	
	   <![CDATA[ A different kind of genetic analysis, whole exome sequencing, of some of the participants in the GRAVITAS trial has led to the discovery of two new genes believed to be critical to platelet function. This novel approach holds much promise in general for the assessment of response to drugs, says the researcher. ]]>
	
	</description>
	<pubDate>
	Sat, 24 Mar 2012 15:20:38 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1374065.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1374013.do</link>
	<title>RESET: Three months of DAPT with Endeavor stent safe as conventional DAPT</title>
	<description>
	
	   <![CDATA[ Treatment with aspirin and thienopyridine therapy for three months with the Endeavor stent was noninferior to standard 12-month dual antiplatelet therapy in patients treated with other DES in terms of the primary end point, a composite of death from cardiovascular causes, MI, stent thrombosis, target vessel revascularization, or bleeding at one year. ]]>
	
	</description>
	<pubDate>
	Sat, 24 Mar 2012 13:45:19 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1374013.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1373903.do</link>
	<title>TRA 2&#176;P-TIMI 50: Future possible for vorapaxar in patients with prior MI?</title>
	<description>
	
	   <![CDATA[ <b><i>UPDATED WITH COMMENTARY</i></b> // The novel antiplatelet agent may have a net clinical benefit in selected secondary-prevention patients, particularly those with a prior MI without a history of stroke or TIA and who weigh over 60 kg. But many experts not involved in the trial were concerned about the bleeding risk with the drug, with suggestions that it may not be suitable for general availability.  ]]>
	
	</description>
	<pubDate>
	Sat, 24 Mar 2012 09:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1373903.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1373865.do</link>
	<title>FOCUS-CCTRN: Negative trial, but hints for future of cell therapy in heart failure </title>
	<description>
	
	   <![CDATA[ The largest study to date of autologous bone-marrow-cell therapy in patients with chronic ischemic heart failure has shown no significant effect on the prespecified end points but did suggest an improvement in LVEF that was related to the number of progenitor cells in the bone marrow.   ]]>
	
	</description>
	<pubDate>
	Sat, 24 Mar 2012 09:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1373865.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1373829.do</link>
	<title>Everolimus DES: Stent-thrombosis advantage vs bare-metal stents in meta-analysis</title>
	<description>
	
	   <![CDATA[ Stents like the widely used Xience V showed a lower rate at one year and at other time points compared with bare-metal stents and some other drug-eluting stents in 50 000-patient meta-analysis. ]]>
	
	</description>
	<pubDate>
	Fri, 23 Mar 2012 18:45:02 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1373829.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1372913.do</link>
	<title>Cardiologists are happy(ish), married non-tweeters, survey reveals </title>
	<description>
	
	   <![CDATA[ Cardiologists, for the most part, drive Japanese cars, believe in a higher power, and are moderately savvy when it comes to social media. Those are just some of the cardiology pearls from a recent "lifestyle survey" of physicians. ]]>
	
	</description>
	<pubDate>
	Thu, 22 Mar 2012 17:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1372913.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1373399.do</link>
	<title>Poor prognosis for big between-arm BP differences in primary care </title>
	<description>
	
	   <![CDATA[ The first research to look specifically at how interarm differences in systolic blood pressure in a primary-care setting relate to future outcomes has found that those with a double-digit difference have a threefold increased risk of death over 10 years. ]]>
	
	</description>
	<pubDate>
	Thu, 22 Mar 2012 14:30:29 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1373399.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1373121.do</link>
	<title>Investigational antibody to PCSK9 reduces LDL-cholesterol levels</title>
	<description>
	
	   <![CDATA[ Three new phase 1 studies of an investigational human monoclonal antibody specific to PCSK9 significantly reduced LDL-cholesterol levels in a group of healthy volunteers and in subjects with familial and nonfamilial forms of hypercholesterolemia. ]]>
	
	</description>
	<pubDate>
	Wed, 21 Mar 2012 17:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1373121.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1373029.do</link>
	<title>Latest Canadian AF guidelines encourage new oral anticoagulants </title>
	<description>
	
	   <![CDATA[ The Canadian Cardiovascular Society has updated its guidelines on atrial fibrillation to reflect some major new findings that have been reported during the past year or so.  ]]>
	
	</description>
	<pubDate>
	Wed, 21 Mar 2012 16:30:07 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1373029.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1372671.do</link>
	<title>Circulating endothelial-cell test may predict plaque ruptures</title>
	<description>
	
	   <![CDATA[ A group at Scripps Translational Science Institute is developing a blood test that uses circulating endothelial cells to spot a plaque rupture in progress. ]]>
	
	</description>
	<pubDate>
	Wed, 21 Mar 2012 14:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1372671.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1372803.do</link>
	<title>Orthostatic hypotension ups risk of HF by 50% </title>
	<description>
	
	   <![CDATA[ New data from the ARIC study show that those with orthostatic hypotension have a higher risk of developing heart failure over 17 years of follow-up. ]]>
	
	</description>
	<pubDate>
	Wed, 21 Mar 2012 12:00:44 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1372803.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1372559.do</link>
	<title>Higher death rate with &quot;off-pump&quot; vs &quot;on-pump&quot; CABG: Cochrane review </title>
	<description>
	
	   <![CDATA[ The authors conclude that CABG should be routinely performed "on pump," and "off-pump" surgery should be reserved for patients with contraindications to aortic cannulation. ]]>
	
	</description>
	<pubDate>
	Tue, 20 Mar 2012 17:30:21 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1372559.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1372525.do</link>
	<title>Another study questions epinephrine for out-of-hospital cardiac arrest </title>
	<description>
	
	   <![CDATA[ Any short-term gains from giving the drug come with a high cost later, suggest adjusted analyses of a massive national CPR registry. ]]>
	
	</description>
	<pubDate>
	Tue, 20 Mar 2012 16:30:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1372525.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1372487.do</link>
	<title>No benefit of vitamin E in heart failure</title>
	<description>
	
	   <![CDATA[ The addition of vitamin E did reduce the risk of developing heart failure with a normal ejection fraction, but these results need to be confirmed in larger studies, say investigators. ]]>
	
	</description>
	<pubDate>
	Tue, 20 Mar 2012 16:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1372487.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1372409.do</link>
	<title>Renal patients with ACS don&#39;t benefit from antiplatelets  </title>
	<description>
	
	   <![CDATA[ In the first-ever meta-analysis to mine antiplatelet trials for specific data on kidney-disease patients, researchers find that there is little evidence of benefit for agents such as clopidogrel in renal patients with acute coronary syndrome, but there is a risk of harm from major bleeding. Those at risk for or with stable coronary disease do appear to gain from antiplatelets, however, in the form of fewer MIs.  ]]>
	
	</description>
	<pubDate>
	Tue, 20 Mar 2012 11:30:36 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1372409.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1372111.do</link>
	<title>Merck abandons oral vernakalant</title>
	<description>
	
	   <![CDATA[ The decision is based on its "assessment of the regulatory environment and projected development timeline," according to company officials.  ]]>
	
	</description>
	<pubDate>
	Mon, 19 Mar 2012 16:30:23 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1372111.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1370967.do</link>
	<title>Nonphysicians pinpoint those at high CVD risk in rural India</title>
	<description>
	
	   <![CDATA[ Employing nonphysician healthcare workers to go into villages in India, spot those at high risk of CVD, and recommend appropriate therapies holds promise as a way of tackling the CVD epidemic affecting the country, say the authors of a new study.  ]]>
	
	</description>
	<pubDate>
	Mon, 19 Mar 2012 16:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1370967.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1372071.do</link>
	<title>Drug-coated balloon reduces restenosis over long term</title>
	<description>
	
	   <![CDATA[ The paclitaxel-coated balloon showed promise as a treatment for in-stent restenosis in early trials, but whether the results would hold up over the long term was not evident until the release of the five-year follow-up data. ]]>
	
	</description>
	<pubDate>
	Mon, 19 Mar 2012 16:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1372071.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1371151.do</link>
	<title>What&#39;s going to be hot at ACC 2012</title>
	<description>
	
	   <![CDATA[ There are 18 late-breaking clinical trials, many addressing unresolved issues with already-approved products or procedures.  Outside the main tent, the program offers debates, live and taped cases, a new Q&amp;A series with "legends" in cardiology, plus a novel gambit for attracting attendees to the exposition: a "thought leaders' theater" located in the exhibit hall. ]]>
	
	</description>
	<pubDate>
	Mon, 19 Mar 2012 14:00:51 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1371151.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1368829.do</link>
	<title>Life on a 12-hour charge: Seeking community in the LVAD age </title>
	<description>
	
	   <![CDATA[ For people living with a left ventricular assist device, knowing a few simple tricks can make life a bit easier. Others with LVADs make good teachers, but increasingly, LVAD recipients are looking online for answers to their questions. ]]>
	
	</description>
	<pubDate>
	Mon, 19 Mar 2012 11:45:08 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1368829.do</guid>
	</item>

	
	
	<item>
	<link>http://www.theheart.org/article/1371249.do</link>
	<title>Soccer star&#39;s cardiac arrest&#160;prompts screening questions </title>
	<description>
	
	   <![CDATA[ The dramatic collapse and resuscitation attempts following the cardiac arrest of a 23-year-old UK soccer player, Fabrice Muamba, this weekend have prompted calls for wider cardiac screening of athletes here. But as a top-class player, Muamba is likely to have been screened, experts told <b>heart</b><b><i>wir</i></b><b><i>e</i></b>, with one theorizing that his arrest was likely caused by a rare condition. ]]>
	
	</description>
	<pubDate>
	Mon, 19 Mar 2012 11:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/1371249.do</guid>
	</item>

</channel>
</rss>


